
Pfizer Inc. said Monday that its coronavirus vaccine provides long-term protection in youth ages 12-15, according to data from a company clinical trial that included more than 2,200 participants. In a company clinical trial that included more than 2,200 adolescents, getting two doses of the vaccine was 100% effective against the coronavirus from seven days… read on > read on >